Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4746  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
   Next article
   Previous article 
   Table of Contents
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (49 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this Article

 Article Access Statistics
    PDF Downloaded141    
    Comments [Add]    

Recommend this journal

Year : 2004  |  Volume : 52  |  Issue : 4  |  Page : 511-512

Diagnostic approach for adult mitochondriopathy with limited resources

Department of Neurology, Krankenanstalt Rudolfstiftung, Univ.Doz. DDr. J. Finsterer, Postfach 20, 1180 Wien, Austria, United Kingdom

Date of Acceptance01-Dec-2004

Correspondence Address:
Department of Neurology, Krankenanstalt Rudolfstiftung, Univ.Doz. DDr. J. Finsterer, Postfach 20, 1180 Wien, Austria, United Kingdom

How to cite this article:
Finsterer J. Diagnostic approach for adult mitochondriopathy with limited resources . Neurol India 2004;52:511-2

How to cite this URL:
Finsterer J. Diagnostic approach for adult mitochondriopathy with limited resources . Neurol India [serial online] 2004 [cited 2019 Aug 24];52:511-2. Available from:


We appreciated reading the paper by Challa et al.[1] on the findings in 60 adult patients with respiratory-chain-disorder (RCD), diagnosed during 12y according to Bernier's criteria.[2] The study raises the following concerns:

What was the indication for muscle-biopsy in those patients without evidence for myopathy? Only 18/60 patients presented with proximal weakness, only 5/35 had elevated CK, and only 12/31 myopathic EMG.

Why was the left vastus lateralis muscle chosen in all cases? It appears unlikely that this muscle was affected in all 60 patients, given the facts that 26 had only chronic external ophthalmoplegia (CPEO), that only 3 of those with CPEO and other signs had myopathy, and that only 30% had proximal weakness. Thus, RRFs >2% in 25/60 investigated muscles suggests subclinical involvement of certain limb muscles in MCP.

Why did only 8% of the patients present with additional non-neurological manifestations? Multisystem involvement is a dominant feature in the majority of MCP patients.[3] Could the low number of patients with cardiac involvement result from the small number of patients undergoing comprehensive cardiologic examination? Only 35 had an ECG and only 13 underwent echocardiography. Which specific abnormalities were found in the 13 who underwent echocardiography? Did the investigators also look for left-ventricular hypertrabeculation?

Also noteworthy are the low prevalence of diabetes, hyper-CK-aemia, and polyneuropathy. In a retrospective study on 130 MCP-patients, the prevalence of diabetes was 12%,[3] that of hyper-CK-aemia 42%, and that of polyneuropathy 35%.[3]

Latency between onset and diagnosis was relatively short. The number of 6.7y remains questionable given the fact that mean age at onset was 19.7y and mean age at diagnosis 29.3y.

We don't agree with the statement that MCP is mostly associated with various central-nervous-system (CNS) symptoms. Although subclinical abnormalities, like cortical or cerebellar atrophy, homogenous parieto-temporal hyperintesities, non-specific white matter lesions, or uni- or bilateral basal ganglia calcifications are often found in adult MCP patients, overt CNS-affection, including dementia, migraine, stroke, Parkinson syndrome, spasticity, ataxia, or dystonia, is rather rare among adults. The authors themselves report only 5/60 patients presenting with encephalomyopathy.

Overall, there is subclinical muscle-affection in MCP long before any clinical manifestation; MCP can be diagnosed even without sophisticated and cost-expensive methods; there is multi-organ involvement in MCP; onset of MCP is quite variable, and patients with suspected MCP should be thoroughly investigated for clinical and subclinical affection of the CNS, PNS, endocrinologic system, heart, eyes, ears, guts, dermis, and bone-marrow. 

  References Top

1.Challa S, Kanikannan MA, Murthy JMK, Bhoompally VR, Surath M. Diagnosis of mitochondrial disease: Clinical and Histologic study of sixty patients with ragged red fibers. Neurol India 2004;52:353-8.  Back to cited text no. 1    
2.Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR. Diagnsotic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406-11.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Finsterer J, Jarius C, Eichberger H, Jaksch M. Phenotype variability in 130 adult patients with respiratory chain disorder. J Inher Metab Dis 2001;24:560-76.  Back to cited text no. 3    


Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow